Literature DB >> 2160580

Transformation by v-myb correlates with trans-activation of gene expression.

T Lane1, C Ibanez, A Garcia, T Graf, J Lipsick.   

Abstract

The v-myb oncogene of avian myeloblastosis virus causes acute myelomonocytic leukemia in chickens and transforms avian myeloid cells in vitro. Its protein product p48v-myb is a nuclear, sequence-specific, DNA-binding protein which activates gene expression in transient DNA transfection studies. To investigate the relationship between transformation and trans-activation by v-myb, we constructed 15 in-frame linker insertion mutants. The 12 mutants which transformed myeloid cells also trans-activated gene expression, whereas the 3 mutants which did not transform also did not trans-activate. This implies that trans-activation is required for transformation by v-myb. One of the transformation-defective mutants localized to the cell nucleus but failed to bind DNA. The other two transformation-defective mutants localized to the cell nucleus and bound DNA but nevertheless failed to trans-activate. These latter mutants define two distinct domains of p48v-myb which control trans-activation by DNA-bound protein, one within the amino-terminal DNA-binding domain itself and one in a carboxyl-terminal domain which is not required for DNA binding.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160580      PMCID: PMC360617          DOI: 10.1128/mcb.10.6.2591-2598.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Reversibility of differentiation and proliferative capacity in avian myelomonocytic cells transformed by tsE26 leukemia virus.

Authors:  H Beug; P A Blundell; T Graf
Journal:  Genes Dev       Date:  1987-05       Impact factor: 11.361

2.  DNA-binding activity associated with the v-myb oncogene product is not sufficient for transformation.

Authors:  C E Ibanez; A Garcia; U Stober-Grässer; J S Lipsick
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  env-encoded residues are not required for transformation by p48v-myb.

Authors:  J S Lipsick; C E Ibanez
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

Review 4.  Multiple functional domains in the adenovirus E1A gene.

Authors:  E Moran; M B Mathews
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

5.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

7.  Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation.

Authors:  C E Ibanez; J S Lipsick
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

8.  Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation.

Authors:  M F Clarke; J F Kukowska-Latallo; E Westin; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

9.  The highly conserved amino-terminal region of the protein encoded by the v-myb oncogene functions as a DNA-binding domain.

Authors:  K H Klempnauer; A E Sippel
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

10.  The regulatory c1 locus of Zea mays encodes a protein with homology to myb proto-oncogene products and with structural similarities to transcriptional activators.

Authors:  J Paz-Ares; D Ghosal; U Wienand; P A Peterson; H Saedler
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  22 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.

Authors:  O Burk; S Worpenberg; B Haenig; K H Klempnauer
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.

Authors:  C Garrido; D Leprince; J S Lipsick; D Stehelin; D Gospodarowicz; S Saule
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Protein truncation is required for the activation of the c-myb proto-oncogene.

Authors:  F A Grässer; T Graf; J S Lipsick
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

Authors:  S C Kenney; E Holley-Guthrie; E B Quinlivan; D Gutsch; Q Zhang; T Bender; J F Giot; A Sergeant
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

6.  Predicted common structural features of DNA-binding domains from Ets, Myb and HMG transcription factors.

Authors:  M P Laget; I Callebaut; Y de Launoit; D Stehelin; J P Mornon
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

7.  Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.

Authors:  A E Cuddihy; L A Brents; N Aziz; T P Bender; W M Kuehl
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae.

Authors:  R H Chen; J S Lipsick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  Individual repeats of Drosophila Myb can function in transformation by v-Myb.

Authors:  X Bin; J S Lipsick
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Protein truncation is not required for c-myb proto-oncogene activity in neuroretina cells.

Authors:  C Garrido; F Grässer; J S Lipsick; D Stehelin; S Saule
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.